Oasmia Pharmaceutical AB

(OASM) Trade

By |

Profile

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells a new generation of drugs within human and veterinary oncology. It focuses on the development of manufacturing activity of novel formulations based on cytostatic which shows improved properties, a reduced side-effect profile, and an expanded therapeutic area. The products and product candidates utilize a proprietary, nanoparticle formulation technology that is designed to facilitate the administration of intravenously-delivered active pharmaceutical ingredients, without the addition of toxic solvents.

Contact Information

Website: www.oasmia.com
Email: anders.blom@oasmia.com
Main Phone: +46 18505440
Address: Vallongatan 1
City / Town: Uppsala
Country: SWE
Postal Code: SE-752 28

Issuer Information

Exchange: NSC
CEO: Mikael Asp
Employees: 57
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 3.39 $ -0.06 (-1.74%)
Last Price 3.39 Change $ -0.06 Change % -1.74 Tick N/A
Bid N/A Bid Size 0.00 Ask 3.58 Ask Size 700.00
Open 3.41 High 3.47 Low 3.37 Prev Close 3.45
Last Trade Volume 4,925 52 Wk Hi 5.70 52 Wk Low 0.85
Market Cap 226.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 66,841,180.00 EPS (TTM) -0.27 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 6 6 6 6
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 6 6 6 6
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 09/12/16 09/12/16 09/12/16 09/12/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1